Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study.

Overview publication

TitlePatient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study.
Date2022-10-01
Issue nameJournal of the American Academy of Dermatology
Issue numberv87.4:920-922
DOI10.1016/j.jaad.2021.12.039
PubMed34973976
AuthorsFraes Diernæs JE, Kromann CB, Boel M, Bygum A & Jemec GBE
Read Read publication